Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jiangwei Ni"'
Publikováno v:
Arabian Journal of Chemistry, Vol 17, Iss 5, Pp 105725- (2024)
Ellagic acid (C14H6O8, 4,4′,5,5′6,6′-hexahydroxydiphenic acid 2,6,2′6′-dilactone) as a metabolite polyphenol compound has shown potential anticancer activities. However, its potential interaction affinity with plasma carrier proteins and an
Externí odkaz:
https://doaj.org/article/8c98e5422253434d9667f4feb5650b19
Publikováno v:
PLoS ONE, Vol 18, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/876a8c475a3c46fabfbb7fa54960c8ad
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Lung large cell neuroendocrine carcinoma (LCNEC) is a rare and highly aggressive malignancy with a dismal prognosis. This study was designed to depict patterns of distant organ metastatic and to analyze prognosis of LCNEC patients. We gathered data f
Externí odkaz:
https://doaj.org/article/6a9249d3d45d421080c9510613eeaa7a
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 115, Iss , Pp - (2019)
Non-small cell lung cancer (NSCLC) is demonstrated as one of the most common malignant tumors and accounts for about 25% of cancer-related deaths each year. Extensive bodies of studies have manifested that microRNAs (miRNAs) play pivotal roles in the
Externí odkaz:
https://doaj.org/article/c6e6094686a94d3baed3554b75deb517
Publikováno v:
Journal of Chinese Pharmaceutical Sciences; May2024, Vol. 33 Issue 5, p430-437, 8p
Publikováno v:
Biochemical and Biophysical Research Communications. 567:154-160
Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase and mutations in EGFR is a major driver force of lung cancer. EGFR tyrosine kinase inhibitors (TKIs) are group of promising agents to treat cancer patients with EGFR mutations. How
Publikováno v:
International Journal of Biological Macromolecules. 242:124821
Esculin alleviates LPS-induced acute lung injury via inhibiting neutrophil recruitment and migration
Publikováno v:
International Immunopharmacology. 119:110177
Autor:
Zhiwei Huang, Sufeng Guo, Wen Chen, Meirong Huang, Jiangwei Ni, Qiqi Zhou, Mingshuo Tian, Xiaomin Wu, Huawang Zhao, Huazhen Shen, Wei Li, Guohua Jing
Publikováno v:
Chemical Engineering Journal. 464:142540
Publikováno v:
Cancer Management and Research
Yuanbo Wu,1,* Jiandong Zhang,2,* Jiangwei Ni,2 Zhihao Yang,2 Kun Chen,2 Liangcheng Zheng,2 Zhifeng He2 1Department of Cardiothoracic Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of China; 2Departm